Zobrazeno 1 - 10
of 134
pro vyhledávání: '"Dang YW"'
Publikováno v:
Cancer Management and Research, Vol Volume 11, Pp 4825-4837 (2019)
Zhi-Min Chen,* Qiao Yu,* Gang Chen, Rui-Xue Tang, Dian-Zhong Luo, Yi-Wu Dang, Dan-Ming WeiDepartment of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China*These authors contributed equally to thi
Externí odkaz:
https://doaj.org/article/cd094f711327470c9722ba782e24701a
Publikováno v:
Cancer Management and Research, Vol Volume 10, Pp 6921-6936 (2018)
Yu Zhang,1,* Li-jie Zhang,1,* Yi-wu Dang,1 Sheng-hua Li,2 Hai-biao Yan,2 Gang Chen1 1Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China; 2Urology, First Affiliated
Externí odkaz:
https://doaj.org/article/96a8e219b230430a86973fe6a79cf059
Publikováno v:
Cancer Management and Research, Vol Volume 12, Pp 461-462 (2020)
Zhang Y, Zhang L-J, Dang Y-W, Li S-H, Yan H-B, Chen G. Clinical significance and effect of MTDH/AEG-I in bladder urothelial cancer: a study based on immunohistochemistry, RNA-seq, and in vitro verification. Cancer Manag Res. 2018;10:6921– 6936.At t
Externí odkaz:
https://doaj.org/article/94af64cecfe540ba94ecef5683ab59b2
Publikováno v:
OncoTargets and Therapy, Vol Volume 12, Pp 953-958 (2019)
Xiao-Ping Zou,1 Yao-Ying Jiang,1 Yan Liao,1 Yi-Wu Dang,1 Gang Chen,1 Zhen-Bo Feng,1 Yun Ma1,2 1Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China; 2Department of Path
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::df4455609d1cea86da14248492387321
https://www.dovepress.com/the-coexistence-of-a-wilms-tumor-and-renal-cell-carcinoma-in-children-peer-reviewed-article-OTT
https://www.dovepress.com/the-coexistence-of-a-wilms-tumor-and-renal-cell-carcinoma-in-children-peer-reviewed-article-OTT
Publikováno v:
OncoTargets and Therapy, Vol Volume 10, Pp 3991-4005 (2017)
Zu-cheng Xie,1,* Yi-wu Dang,1,* Dan-ming Wei,1 Peng Chen,1 Rui-xue Tang,1 Qian Huang,1 Jiang-hua Liu,1,2,* Dian-zhong Luo1,* 1Department of Pathology, 2Department of Emergency Medicine, First Affiliated Hospital of Guangxi Medical University, Nanning
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::8aded229ef2e7bb0d18017317e7d2b34
https://www.dovepress.com/clinical-significance-and-prospective-molecular-mechanism-of-malat1-in-peer-reviewed-article-OTT
https://www.dovepress.com/clinical-significance-and-prospective-molecular-mechanism-of-malat1-in-peer-reviewed-article-OTT
Publikováno v:
OncoTargets and Therapy, Vol 2016, Iss Issue 1, Pp 4959-4968 (2016)
Yu Zhang,1,* Jie Luo,2,* Rongquan He,3 Wenting Huang,1 Zuyun Li,1 Ping Li,1 Yiwu Dang,1 Gang Chen,1 Shikang Li4 1Department of Pathology, 2Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, 3Center for Genomic an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::df2fc5f6c9ceaadd3b70876dba0337e7
https://www.dovepress.com/expression-and-clinicopathological-implication-of-dcr3-in-lung-cancer--peer-reviewed-article-OTT
https://www.dovepress.com/expression-and-clinicopathological-implication-of-dcr3-in-lung-cancer--peer-reviewed-article-OTT
Publikováno v:
OncoTargets and Therapy, Vol Volume 9, Pp 5163-5180 (2016)
Wen-Ting Huang,1,* Han-Lin Wang,1,* Hong Yang,2 Fang-Hui Ren,1 Yi-Huan Luo,1 Chun-Qin Huang,1 Yue-Ya Liang,1 Hai-Wei Liang,1 Gang Chen,1 Yi-Wu Dang1 1Department of Pathology, 2Department of Ultrasonography, First Affiliated Hospital of Guangxi Medica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::bcadd1f0f630e855dd8d88260cfa9440
https://www.dovepress.com/lower-expressed-mir-198-and-its-potential-targets-in-hepatocellular-ca-peer-reviewed-article-OTT
https://www.dovepress.com/lower-expressed-mir-198-and-its-potential-targets-in-hepatocellular-ca-peer-reviewed-article-OTT
Publikováno v:
OncoTargets and Therapy, Vol 2016, Iss Issue 1, Pp 1721-1734 (2016)
Jianjun Li,1,* Lu Liang,2,* Yongru Liu,2 Yihuan Luo,2 Xiaona Liang,2 Dianzhong Luo,2 Zhenbo Feng,2 Yiwu Dang,2 Lihua Yang,3 Gang Chen2 1Department of General Surgery, Western Branch, First Affiliated Hospital of Guangxi Medical University, Nanning, G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::4e598a6b32c1281cc9337e6d7f1b2add
https://www.dovepress.com/clinicopathological-significance-of-stat4-in-hepatocellular-carcinoma--peer-reviewed-article-OTT
https://www.dovepress.com/clinicopathological-significance-of-stat4-in-hepatocellular-carcinoma--peer-reviewed-article-OTT
Autor:
Wen JY; Department of Radiotherapy, The Second Affiliated Hospital of Guangxi Medical University, Nanning, P. R. China., Fang YY; Department of Radiotherapy, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. China., Li DM; Department of Pathology, Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. China., Tang YL; Department of Pathology, Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. China., Huang HQ; Department of Radiotherapy, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. China., Liu LM; Department of Toxicology, College of Pharmacy, Guangxi Medical University, Nanning, P.R. China., Zeng JH; Department of Clinical Laboratory, The Third Affiliated Hospital of Guangxi Medical University/Nanning Second People's Hospital, Nanning, P. R. China., Dang YW; Department of Pathology, Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. China., Pan YF; Department of Pathology, Hospital of Guangxi Liugang Medical Co., LTD./Guangxi Liuzhou Dingshun Forensic Expert Institute, Liuzhou, P.R. China., Zeng DT; Department of Pathology, Redcross Hospital of Yulin city, Yulin, P.R. China., Huang WJ; Department of Pathology, Redcross Hospital of Yulin city, Yulin, P.R. China., Chen G; Department of Pathology, Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. China., Li H; Department of Colorectal & Anal Surgery, Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. China.
Publikováno v:
Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2024 Nov; Vol. 39 (9), pp. 673-689. Date of Electronic Publication: 2024 Aug 19.
Autor:
Li GS; Department of Cardiothoracic Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People's Republic of China., Huang ZG; Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People's Republic of China., He RQ; Department of Medical Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People's Republic of China., Zhang W; Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People's Republic of China., Tang YX; Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People's Republic of China., Liu ZS; Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People's Republic of China., Gan XY; Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People's Republic of China., Tang D; Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People's Republic of China., Li DM; Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People's Republic of China., Tang YL; Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People's Republic of China., Zhan YT; Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People's Republic of China., Dang YW; Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People's Republic of China., Zhou HF; Department of Cardiothoracic Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People's Republic of China., Zheng JH; Department of Pathology, The Affiliated Hospital of Guilin Medical University, Guilin, 541001, People's Republic of China., Jin MH; Department of Pathology, The Affiliated Hospital of Guilin Medical University, Guilin, 541001, People's Republic of China., Tian J; Department of Pathology, The Affiliated Hospital of Guilin Medical University, Guilin, 541001, People's Republic of China., Chen G; Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People's Republic of China. chengang@gxmu.edu.cn.
Publikováno v:
Molecular biotechnology [Mol Biotechnol] 2024 Oct; Vol. 66 (10), pp. 2956-2971. Date of Electronic Publication: 2023 Oct 17.